iCON - Standardized facility methodologies to deliver innovation and realize a targeted mission

Since the advent of the human genome, the pharmaceutical industry has seen prolific scientific growth as new therapies are being developed; some therapies treat conditions formerly untreatable, while others have the potential to reduce the contraction of serious disease or even cure cancer. With lives sometimes literally at stake, our clients and their patients need a construction delivery solution that not only defers financial risk as long as possible, but rapidly skips to the end when drug efficacy confidence is high. Regardless of all the drug approval and regulatory requirements, we need to complete the mission of getting critical medicines and innovative therapies to patients sooner.

To read more, go to: https://themedicinemaker.com/product-profiles/mission-driven-architecture